Page 2 - Bioscience Inc News Today

HC Wainwright reiterated their buy rating on shares of Daré Bioscience (NASDAQ:DARE – Free Report) in a report published on Wednesday morning, Benzinga reports. They currently have a $6.00 price objective on the biotechnology company’s stock. A number of other research analysts also recently issued reports on the stock. Dawson James downgraded shares of Daré […]

Yield10 Bioscience, Inc. (NASDAQ:YTEN – Free Report) shares are set to reverse split on Friday, May 3rd. The 1-24 reverse split was announced on Friday, May 3rd. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, May 3rd. Yield10 Bioscience Stock Down 8.4 % YTEN stock traded down […]

Yield10 Bioscience (NASDAQ:YTEN – Get Free Report) and Grown Rogue International (OTCMKTS:GRUSF – Get Free Report) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability and dividends. Volatility & Risk Yield10 Bioscience […]

Daré Bioscience (NASDAQ:DARE – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a report released on Wednesday, Benzinga reports. They currently have a $6.00 price target on the biotechnology company’s stock. Several other research analysts have also weighed in on the stock. Dawson James lowered shares of […]

(RTTNews) - Yield10 Bioscience, Inc. (YTEN), an agricultural bioscience company, on Wednesday announced a 1-for-24 reverse stock split on May 2, w...

According to Market.Us, the global agricultural biotechnology market was assessed at US$ 111 billion in 2022. Projections suggest it is poised to reach approximately US$ 232 billion by 2032. During the period spanning from 2023 to 2032, analysts anticipate this market to exhibit the highest Compound Annual Growth Ra...

Yield10 Bioscience (NASDAQ:YTEN – Get Free Report) and Grown Rogue International (OTCMKTS:GRUSF – Get Free Report) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, profitability, valuation and dividends. Analyst Recommendations This is a […]

23.04.2024 - Daré Bioscience’s DARE-LARC1 Platform Technology has Transformative Potential for Women’s Health as well as in Treating a Broad Range of Diseases Strategic Process Underway to Explore Partnering Opportunities for Additional Indications such as ... Seite 1

Factor Bioscience Inc., a Cambridge-based biotechnology company focused on developing mRNA and cell-engineering technologies, announced its participation in the